Chinese Markets for Hepatitis Drugs


#113933

169pages

Asia Market Information & Development Company

$ 4000

In Stock


China's demand for hepatitis drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major producers in China are profiled.
TABLE OF CONTENTS

I. INTRODUCTION 
Report Scope and Methodology
Executive Summary

II. BUSINESS ENVIRONMENT
Economic Outlook
Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade
Financial and Tax Regulations
Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties

III. HEPATITIS DRUGS INDUSTRY ASSESSMENTS
Hepatitis Drugs Industry Structure
Market Size
Market Growth Drivers
Hepatitis Drugs Industry Sales Volumes
Major Producer Facility Locations and Sales Volumes
Market Share of Key Producers
Labor Cost
Potential Entrants
Major Distributors
Major Foreign Investment
Technology Development

IV. HEPATITIS DRUGS PRODUCTION AND DEMAND 
Overview
Sales Volumes of Hepatitis Drugs by Region in 2011
Hepatitis Drugs Sales Volumes
Liver Protection Drugs
Nucleoside Drugs
Interferon (IFN)
Other Hepatitis Drugs
Hepatitis Drugs Imports and Exports
Hepatitis Drugs Imports
Hepatitis Drugs Exports
Pricing Trend

V. HEPATITIS DRUGS MARKET OUTLOOK 
Hepatitis Drugs Market Outlook Overview 
Government Regulation
Health Care Insurance Industry Overview
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits

VI. MARKETING STRATEGIES 
China Market Entry Overview
Chinas Distribution System
Hepatitis Drugs Distribution Channels
Transportation and Freight Infrastructure
Communications
Chinas Market Entry
Export to China
Indirect export
Direct Export
License and Contract Manufacture
Assembling in China
Contract Manufacturing
Trade Permit
Investment
Equity Joint Venture
Contractual Joint Venture
Wholly Foreign-Owned Enterprise

VII. HEPATITIS DRUGS PRODUCER DIRECTORY
Hepatitis Drugs Producer Profiles 

I. INTRODUCTION 
Economic Outlook Summary 

II. BUSINESS ENVIRONMENT 
Key Economic Indicators 
Industrial Output
Population and Labor Force Trends 
Foreign Investment and Loans 
Foreign Trade 

III. HEPATITIS DRUGS INDUSTRY ASSESSMENTS 
Hepatitis Drugs Industry Sales Volumes 
Major Producer Facility Locations 
Major Hepatitis Drugs Producer Sales Volumes 
Market Share of Key Producers 
Major Foreign Investments in China 

IV. HEPATITIS DRUGS PRODUCTION AND DEMAND 
Hepatitis Drugs Sales Volumes
Sales Volumes of Hepatitis Drugs by Region in 2011
Major Liver Protection Drugs Producer Sales Volumes
Liver Protection Drugs Sales Volumes
Major Nucleoside Drugs Producer Sales Volumes
Nucleoside Drugs Sales Volumes
Major IFN Drugs Producer Sales Volumes
Interferon (IFN) Sales Volumes
Other Hepatitis Drugs Sales Volumes
China Hepatitis Drugs Imports and Exports

V. HEPATITIS DRUGS MARKET OUTLOOK 
Total hepatitis Drugs Sales Volumes by Market
Hepatitis Drugs Sales Volumes and Market Share in 2011
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits
I. INTRODUCTION 
Chinas Hepatitis Drugs Sales Volumes 

II. BUSINESS ENVIRONMENT 
Chinas GDP and Growth Rate 
Industrial Output by Ownership
Chinas Imports and Exports 

III. HEPATITIS DRUGS INDUSTRY ASSESSMENTS 

Hepatitis Drugs Sales Volumes in China 

IV. HEPATITIS DRUGS PRODUCTION AND DEMAND 
Total Hepatitis Drugs Sales Volumes 
Total Hepatitis Drugs Imports and Exports

V. HEPATITIS DRUGS MARKET OUTLOOK 
Hepatitis Drugs Sales Volumes by Market in 2011

VI. MARKETING STRATEGIES
Chinas Distribution Channel